Imm Ecosystem Partnership Lead - Mid Atlantic

Apply now

Date: May 28, 2019

Location: Baltimore, Maryland, US

Help us transform patients' lives.

At UCB, we put our heart, soul, and skills into making a difference for people living with severe disease. Working together to push the boundaries, we blend the best of our talents to unlock innovation.  Will you join us in our pioneering adventure?

The Immunology Ecosystem Partnership Lead can be based in the following cities:  DC Metro, Baltimore, MD.


The Immunology Ecosystem Partnership Lead (iEPL) will deliver and differentiate the Immunology total value proposition to C-Suite Executive Population Stakeholders, and Regional Payer and IDN formulary stakeholders – co developing advocacy and influence that delivers on the patient Value Strategy in collaboration with immunology micro-ecosystem partners. The iEPL will assist in achieving patient access to UCB products, jointly coordinated with their Access Accelerator Lead (AAL) and multi-disciplinary immunology partners, through strong differentiation of our value proposition and by connecting immunology micro-ecosystem stakeholders to Regional Payer & IDN immunology stakeholders. IEPL has shared responsibility with “Squad” partners for co-developing payer strategies to be integrated and coordinated with multi-disciplinary members of the local micro-ecosystem. The iEPL is responsible for co-developing and implementing strategies, in coordination with AAL and Squad partners, leveraging iPVU resource expertise - to develop productive relationships with key micro-ecosystem Executive Population Health Stakeholders and key Regional Payer & IDN immunology formulary stakeholders - establishing broad, deep, and coordinated network relationships that achieve affordable product access and maximizes value creation for patients.


The iEPL has primary responsibility of delivering and differentiating the immunology value proposition to C-Suite Executive Population Stakeholders, Large Group Practice, Health System, and key immunology influencers in all micro-ecosystems. The iEPL will have shared responsibility, with their AAL partners, to develop and coordinate strategies that ensure access and affordability of UCB iPVU products with Regional Payer and IDN accounts within their defined micro-ecosystems. 



  • Model and lead strong squad and Immunology Patient Value Team collaboration and teamwork that contributes to achievement of shared objectives
  • In coordination with the AAL partners, co-develop, define, and execute local strategic imperatives focused on maximizing UCB iPVU Product access, affordability, and pull-through within the immunology micro-ecosystems
  • Keen understanding of immunology business including customers, brand marketing implementation strategies, business models, health economics, medical and pharmacy reimbursement, population health, and value based care delivery models
  • Deliver and differentiate high impact immunology value proposition to C-Suite Executive Population Stakeholders, Large Group Practice, Health System, and key immunology influencers in all micro-ecosystems.
  • Develop and lead partnering relationships with immunology executive stakeholders (C-Suite) to influence patient access to UCB iPVU products with local and regional payers/IDNs – across all immunology micro-ecosystems - via co-developed strategic plans shared and coordinated with squad partners
  • Responsible for creating and leading connectivity of iPVU micro-ecosystem executive stakeholders and key immunology influencers to their regional payer/IDN contemporaries, who have influence over immunology formulary and or medical policy decisions - via co-developed and coordinated strategic plans shared by squad partners
  • Deliver the differentiated immunology value proposition to key immunology formulary influencers, developing advocates to optimize patient access, within local and regional payers/IDNs – across all immunology micro-ecosystems incoordination w AAL partners
  • Deep understanding of Regional Payer/IDN business model, functional infrastructure, and internal network connectivity, as well as key decision makers, immunology formulary influencers, and stakeholders
  • Responsible for expanding broader and deeper relationships across diverse Immunology Clinical, Population Health, Utilization Management, Quality Teams, and Value-based care functions etc. - applied to multi-disciplinary formulary advocates internal to regional payers/IDNs strategically coordinated with AAL partners
  • Operates at the highest level of UCB compliance and professional standards.  Compliance is a part of how we operate within UCB.  Adherence to compliant behavior is an expectation at UCB



  • Bachelors’ degree in life sciences, business or healthcare required
  • 5-8 years of immunology and market access experience; sales leadership, marketing, or field medical experience preferred
  • 3+ years in key account management
  • Demonstrated experience and documented success leading multidisciplinary and/or matrixed teams
  • Market expertise in US Immunology, Regional Payer/IDN, and Healthcare delivery systems preferred
  • Demonstrated leadership skills in managing, developing, and influencing teams
  • Demonstrated excellence in written and verbal communications
  • Demonstrated strength in business planning, tactical plan development and execution


UCB is a global biopharmaceutical company. We focus on discovering and developing innovative medicines and lateral solutions that can transform the everyday lives of people with severe diseases of the immune system – or the central nervous system.

With more than 7500 people in approximately 40 countries, UCB offers an exciting working environment where initiative can flourish and those with a ‘can-do’ attitude can thrive.  Scientific excellence, innovation, co-creation, lateral thinking, reinventing the way we do things…these are some of the key competencies we are constantly developing, and looking for, at UCB.

Job Segment: Immunology, Medical, Pharmacy, Healthcare

Apply now